SCHEMBL14926992

SCHEMBL14926992

COc1cc(-c2cc3cc(CO)c(CO)cc3c3nccn23)cc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTAFR P25105 2/20 0.51
▸ FYN P06241 1/20 0.38
▸ PDE5A O76074 4/20 0.35
▸ PDE1B Q01064 4/20 0.35
▸ PDE3A Q14432 4/20 0.35
▸ PDE4A P27815 3/20 0.35
▸ PDE1A P54750 3/20 0.35
▸ PDE4B Q07343 3/20 0.35
▸ PDE4C Q08493 3/20 0.35
▸ PDE4D Q08499 3/20 0.35
▸ PDE3B Q13370 3/20 0.35
▸ PDE1C Q14123 3/20 0.35
▸ PAX8 Q06710 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PDE6A P16499 1/20 0.35
▸ IKBKB O14920 1/20 0.34
▸ SYK P43405 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12070662 0.89 PTAFR (0.51) PTAFRFYNPDE5APDE1BPDE3A
SCHEMBL14927045 0.87 PTAFR (0.49) PTAFRFYNPDE5APDE1BPDE3A
SCHEMBL14903972 0.84 PTAFR (0.40) PTAFRFYNPDE5APDE1BPDE3A
SCHEMBL14903983 0.74 PDGFRB (0.54) FYN
SCHEMBL14906858 0.73 FYN (0.43) PTAFRFYNPAX8KDM4EALDH1A1
SCHEMBL128807 0.72 RAC1 (0.46) PDE5APDE1BPDE3APDE4APDE1A
SCHEMBL14904054 0.71 PDGFRB (0.55) FYN
SCHEMBL14926995 0.71 PDE5A (0.35) FYNPDE5APDE1BPDE3APDE4A
SCHEMBL14903984 0.69 FYN (0.38) FYNPDE5APDE1BPDE3APDE4A
SCHEMBL14904012 0.69 FYN (0.43) FYNSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 PTAFR 3790/4885FYN 3983/4885PDE5A 2129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback